PAPER Coukos R, Krainc D
SEARCH RESULTS
330883 RESULTS
PAPER Boskovic P, Gao W, Kipnis J
Will cellular immunotherapies end neurodegenerative diseases?
Trends Immunol. 2024 Apr 9; PubMed: 38600001PAPER Reda SM, Setti SE, Berthiaume AA, Wu W, Taylor RW, Johnston JL, Stein LR, Moebius HJ, Church KJ
Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease.
Neurotherapeutics. 2024 Apr 9;:e00350. PubMed: 38599894PAPER Bukhari H, Nithianadam V, Battaglia RA, Cicalo A, Sarkar S, Comjean A, Hu Y, Leventhal MJ, Dong X, Feany MB
Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model.
Genome Res. 2024 Apr 10; PubMed: 38599684PAPER Yang Y, Jia X, Yang X, Wang J, Fang Y, Ying X, Zhang M, Wei J, Pan Y
Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
Brain Res. 2024 Apr 8;1835:148920. PubMed: 38599511PAPER Zeng H, Zhang Q, Liu L, Deng F, Han H, Meng F, Bai H
Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer's disease.
Neurochem Int. 2024 Apr 8;:105737. PubMed: 38599243PAPER Makino M, Nakamura S
A novel probe to monitor lysosome-mitochondria contact sites opens up a new path to study neurodegenerative diseases.
Cell Calcium. 2024 Apr 8;120:102887. PubMed: 38599095PAPER
Correction to: Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia.
Brain. 2024 Apr 10; PubMed: 38598531PAPER Bhattarai P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, Jülich D, Tayran H, Yilmaz E, Flaherty D, Turgutalp B, Sukumar G, Alba C, McGrath EM, Hupalo DN, Bacikova D, Le Guen Y, Lantigua R, Medrano M, Rivera D, Recio P, Nuriel T, Ertekin-Taner N, Teich AF, Dickson DW, Holley S, Greicius M, Dalgard CL, Zody M, Mayeux R, Kizil C, Vardarajan BN
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease.
Acta Neuropathol. 2024 Apr 10;147(1):70. PubMed: 38598053PAPER Ng D, Watson N, McDermott EA, Kurucu H, Summers D, Andrews M, Green A, Barria M, McKenzie J, Tam J, Smith C, Pal S
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme.
J Neurol. 2024 Apr 10; PubMed: 38597944PAPER Ghirelli A, Spinelli EG, Canu E, Basaia S, Castelnovo V, Cecchetti G, Sibilla E, Domi T, Magnani G, Caso F, Caroppo P, Prioni S, Villa C, Rossi G, Tremolizzo L, Appollonio I, Verde F, Ticozzi N, Silani V, Filippi M, Agosta F
Clinical and neuroanatomical characterization of the semantic behavioral variant of frontotemporal dementia in a multicenter Italian cohort.
J Neurol. 2024 Apr 10; PubMed: 38597943PAPER Kojak N, Kuno J, Fittipaldi KE, Khan A, Wenger D, Glasser M, Donnianni RA, Tang Y, Zhang J, Huling K, Ally R, Mujica AO, Turner T, Magardino G, Huang PY, Kerk SY, Droguett G, Prissette M, Rojas J, Gomez T, Gagliardi A, Hunt C, Rabinowitz JS, Gong G, Poueymirou W, Chiao E, Zambrowicz B, Siao CJ, Kajimura D
Somatic and intergenerational G4C2 hexanucleotide repeat instability in a human C9orf72 knock-in mouse model.
Nucleic Acids Res. 2024 Apr 10; PubMed: 38597682PAPER Mukherjee S, Poudyal M, Dave K, Kadu P, Maji SK
Protein misfolding and amyloid nucleation through liquid-liquid phase separation.
Chem Soc Rev. 2024 Apr 10; PubMed: 38597222PAPER Bedward A, Kaur J, Seedat S, Donohue H, Kow CS, Rasheed MK, Javed A, Hasan SS
Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials.
Expert Rev Neurother. 2024 Apr 10;:1-13. PubMed: 38597219PAPER Shreeya T, Ansari MS, Kumar P, Saifi M, Shati AA, Alfaifi MY, Elbehairi SE
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases.
Front Aging. 2023;4:1292053. Epub 2024 Mar 21 PubMed: 38596783Current Filters
No filters selected